1. Home
  2. INTZ vs INTS Comparison

INTZ vs INTS Comparison

Compare INTZ & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intrusion Inc.

INTZ

Intrusion Inc.

N/A

Current Price

$0.41

Market Cap

13.1M

ML Signal

N/A

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

N/A

Current Price

$3.03

Market Cap

13.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INTZ
INTS
Founded
1983
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
13.7M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
INTZ
INTS
Price
$0.41
$3.03
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $18.67
AVG Volume (30 Days)
★ 173.6K
12.5K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 71.78
N/A
EPS
★ N/A
N/A
Revenue
★ $7,015,000.00
N/A
Revenue This Year
$22.62
N/A
Revenue Next Year
$26.44
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 21.56
N/A
52 Week Low
$0.47
$0.22
52 Week High
$1.56
$8.06

Technical Indicators

Market Signals
Indicator
INTZ
INTS
Relative Strength Index (RSI) 34.65 42.22
Support Level N/A $0.22
Resistance Level $0.89 $3.58
Average True Range (ATR) 0.08 0.27
MACD -0.01 0.00
Stochastic Oscillator 3.15 36.74

Price Performance

Historical Comparison
INTZ
INTS

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: